C. Polman

1.9k citations

17 papers · 1.4k indexed · 1 hit paper · h-index 10

Pathology and Forensic Medicine top 1%
- Multiple Sclerosis Research Studies 13
- Systemic Sclerosis and Related Diseases 2
Rheumatology top 2%
- Systemic Lupus Erythematosus Research 3
Neurology top 5%
Developmental Neuroscience top 10%
Neurology top 10%
Cardiology and Cardiovascular Medicine
- Viral Infections and Immunology Research 2
Epidemiology
- Herpesvirus Infections and Treatments 2
Molecular Biology
- RNA regulation and disease 2
- Melanoma and MAPK Pathways 1
Oncology
- Polyomavirus and related diseases 2

Co-authors: Frederik Barkhof Bob W. van Oosten L. Truyen Hans‐Peter Hartung J. Woody Jan Boringa Frits W. Bertelsmann B. Mary E. von Blomberg
Cited by: Pathology and Forensic Medicine Rheumatology Neurology
Journals: Neurology (6 papers)Multiple Sclerosis Journal (2 papers)International Archives of Allergy and Immunology (1 paper)
Partner nations: Netherlands Switzerland United Kingdom

In The Last Decade

C. Polman

16 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by C. Polman

Since Specialization

Citations

This map shows the geographic impact of C. Polman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Polman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Polman more than expected).

Fields of papers citing papers by C. Polman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Polman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Polman. The network helps show where C. Polman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside C. Polman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Polman Line = papers co-authored together C. Polman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome Multiple Sclerosis Journal ·M.J. DUNCAN,Christoph Pohl,Mike P. Wattjes,Hanneke E. Hulst,Mark S. Freedman,Hans‐Peter Hartung,David Miller,Xavier Montalbán,Ludwig Kappos,Gilles Edan,Dirk Pleimes,D E Botha,Brigitte Stemper,C. Polman,Rupert Sandbrink,Frederik Barkhof	2013	17
2	Relationship between Timed 25-Foot Walk Walking Speed and Health-Related Quality of Life in AFFIRM and SENTINEL (P07.097) Neurology ·C. Polman,Eva Havrdová,Christian Confavreux,Richard A. Rudick	2012	2
3	Long-term effect of early treatment with interferon-beta-1b after a first clinical event suggestive of multiple sclerosis: 8-year observational extension of the phase 3 BENEFIT trial UCL Discovery (University College London) ·(unknown),Ludwig Kappos,Xavier Montalbán,C. Polman,Vittoria Pereira Valente Lombardi,HP Hartung,David Miller,Frederik Barkhof,甘利貴志,(unknown),Brigitte Stemper,Christoph Pohl,Rupert Sandbrink,Dirk Pleimes	2011	1
4	Betaferon (R)/betaseron (R) in newly emerging multiple sclerosis for initial treatment (benefit): Effects of early vs. delayed treatment with interferon beta-1B UCL Discovery (University College London) ·HP Hartung,Ludwig Kappos,C. Polman,Gilles Edan,D. H. Miller,Xavier Montalbán,Frederik Barkhof,Lars Bauer,S. Dahms,Christoph Pohl,Rupert Sandbrink	2007	0
5	8 year follow-up of the European study of Interferon beta-1b (EUSPMS) in secondary progressive MS UCL Discovery (University College London) ·Jens Kühle,Martin Hardmeier,Manjit Chauhan,Hideo KAKUZEN,C. Polman,I. Achiti,L Kappos,近水野	2004	3
6	Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized study Multiple Sclerosis Journal ·C. Polman,Frederik Barkhof,Ludwig Kappos,Carlo Pozzilli,Rupert Sandbrink,Frank Dahlke,khadiga aboutalb,张刘春,(unknown)	2003	32
7	The effect of interferon β-1b on quantities derived from MT MRI in secondary progressive MS Neurology ·Matilde Inglese,J.H.T.M. van Waesberghe,Marco Rovaris,K. Beckmann,Frederik Barkhof,David W. Hahn,Ludwig Kappos,David H. Miller,C. Polman,Carlo Pozzilli,Alan J. Thompson,Tarek Yousry,Klaus Wagner,Giancarlo Comi,Massimo Filippi	2003	59
8	The effect of IFNβ-1b on the evolution of enhancing lesions in secondary progressive MS Neurology ·P A Brex,P. D. Molyneux,G.M. Cavestro,Frederik Barkhof,Massimo Filippi,Tarek Yousry,David W. Hahn,Yan Rolland,Oili Salonen,Carlo Pozzilli,C. Polman,Alan J. Thompson,Ludwig Kappos,David H. Miller	2001	48
9	Magnetization Transfer Ratio of the Spinal Cord in Multiple Sclerosis: Relationship to Atrophy and Neurologic Disability Journal of Neuroimaging ·Geert J. Lycklama à Nijeholt,Jonas A. Castelijns,R.H.C. Lazeron,Jan Hein van Waesberghe,C. Polman,Bernard M.J. Uitdehaag,Frederik Barkhof	2000	39
10	Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study Journal of Neurology ·Frederik Barkhof,M. W. Tas,Jacob Valk,M. Elton,J. Lindeboom,Stefan Kreis,O. R. Hommes,C. Polman,A. Kok	1998	57
11	Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. American Journal of Neuroradiology ·Jan Hein van Waesberghe,Marianne AA van Walderveen,J.A. Castelijns,Philip Scheltens,Geert J. Lycklama à Nijeholt,C. Polman,Frederik Barkhof	1998	216
12	Interleukin-2 therapy does not exacerbate multiple sclerosis Neurology ·Bob W. van Oosten,Bernard M.J. Uitdehaag,Frederik Barkhof,HP Hartung,John Wagstaff,C. Polman	1997	2
13	4-31-17 MRI protocol for the European trial of beta interferon-1b in secondary progressive multiple sclerosis Journal of the Neurological Sciences ·D. H. Miller,C. Polman,Carlo Pozzilli,L Kappos,Amber Thompson,JamelAbdennaceur Ouali,Teresa Mora,Frank Dahlke	1997	2
14	Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2breakdown → Neurology ·Bob W. van Oosten,Frederik Barkhof,L. Truyen,Jan Boringa,Frits W. Bertelsmann,B. Mary E. von Blomberg,J. Woody,Hans‐Peter Hartung,C. Polman	1996	562
15	Accumulation of hypointense lesions ("black holes") on T ₁ spin-echo MRI correlates with disease progression in multiple sclerosis Neurology ·L. Truyen,J.H.T.M. van Waesberghe,M.A.A. van Walderveen,Bob W. van Oosten,C. Polman,O. R. Hommes,H.J. Adèr,Frederik Barkhof	1996	378
16	Increased Visual Impairment after Exercise (Uhthoff’s Phenomenon) in Multiple Sclerosis: Therapeutic Possibilities European Neurology ·H.A.M. van Diemen,Антонова Анна Валерьевна,Piergiorgio Ferrante,C. Polman	1992	26
17	Presence of Ia-Positive Cells in the Central Nervous System of the Rat during Various Pathological Conditions International Archives of Allergy and Immunology ·C. Polman,C.D. Dijkstra,Corline J.A. De Groot,J.C. Koetsier,T. Sminia	1987	1

About C. Polman

C. Polman is a scholar working on Pathology and Forensic Medicine, Biological Psychiatry and Neurology, having authored 17 papers that have together received 1.4k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (13 papers), Systemic Lupus Erythematosus Research (3 papers), Viral Infections and Immunology Research (2 papers), Herpesvirus Infections and Treatments (2 papers), RNA regulation and disease (2 papers), Systemic Sclerosis and Related Diseases (2 papers), Polyomavirus and related diseases (2 papers) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (1.0k citations), Rheumatology (419 citations) and Neurology (374 citations). C. Polman has collaborated with scholars based in Netherlands, Switzerland and United Kingdom. Frequent co-authors include Frederik Barkhof, Bob W. van Oosten, L. Truyen, Hans‐Peter Hartung, J. Woody, Jan Boringa, Frits W. Bertelsmann, B. Mary E. von Blomberg, O. R. Hommes and J.H.T.M. van Waesberghe. Their work appears in journals such as Neurology, Multiple Sclerosis Journal, International Archives of Allergy and Immunology, Journal of Neuroimaging and Journal of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact